Patents
Patents for C07K 9 - Peptides having up to 20 amino acids, containing saccharide radicals and having a fully defined sequence; Derivatives thereof (3,306)
08/2000
08/30/2000EP1031576A2 Glycopeptide antibiotic derivatives
08/29/2000US6111084 Sialyl lewis mimetics produced by solid phase synthesis; antiinflammatory agents
08/29/2000US6111067 Bactericides against grampositive bacteria
08/17/2000WO2000047605A2 Enterocyte growth factors and method for their isolation
08/09/2000EP1025852A1 Hydrochlorides of vancomycin antibiotics and process for producing the same
08/09/2000EP0640133B1 Recombinant dna molecules encoding aminopeptidase enzymes and their use in the preparation of vaccines against helminth infections
08/03/2000WO2000044335A2 Uridyl peptide antibiotic (upa) derivatives, their synthesis and use
07/2000
07/20/2000WO2000042067A1 Saccharides linked to compounds that bind cell-surface peptides or proteins
07/20/2000WO2000042052A1 Substituted alpha-linked disaccharides
07/20/2000WO2000041710A1 Glycopeptide antibiotics containing a desmethylvancosamine residue, combinatorial libraries of same and methods of producing same
07/19/2000EP1019728A1 Method of activating a novel ligand regulatory pathway
07/18/2000US6090789 Synthesis of the breast tumor-associated antigen defined by monoclonal antibody MBr1 and uses thereof
07/11/2000US6087325 Peptide-lipid conjugates
07/06/2000WO2000039156A1 Glycopeptide derivatives and pharmaceutical compositions containing the same
07/05/2000EP1016672A1 Polypeptide transition metal salts and method of enhancing anti-hiv activity of polypeptide
07/05/2000EP1016670A1 Glycopeptide antibiotic derivatives
06/2000
06/22/2000WO2000035887A2 Vitronectin receptor antagonist pharmaceuticals
06/22/2000CA2349333A1 Vitronectin receptor antagonist pharmaceuticals
06/21/2000EP1009759A1 Carbohydrate crosslinked glycoprotein crystals
06/21/2000CN1053699C Recombinant DNA molecules encoding aminopeptidase enzymes and their use in the preparation of vaccines against helminth infections
06/14/2000EP1007541A1 Randomly generated glycopeptide combinatorial libraries
06/13/2000US6075006 For treatment of arthritis, asthma, inflammation, tumoral growth, gastro intestinal hypermotility, huntington disease, neuritis, neuralgia, migraine, hypertension, incontinence of urine, urticaria, symptoms of the carcinoid syndrome
06/08/2000WO2000032823A1 Dna-protein fusions and uses thereof
06/07/2000CN1255926A 20(S) camptothecin glycoconjugates
06/06/2000US6071532 Synthesis of glycophospholipid and peptide-phospholipid conjugates and uses thereof
05/2000
05/24/2000EP1001805A1 Methods for identifying antibodies and peptides useful in the treatment of septic shock and experimental arthritis and uses thereof
05/23/2000US6066503 Recombinant DNA molecules encoding aminopeptidase enzymes and their use in the preparation of vaccines against helminth infections
05/17/2000CN1253019A Method for preparing medicine composition capable of inhibiting post infective virus proteinase
05/10/2000CN1252809A Modified TNF alpha molecules, DNA encoding such modified TNF alpha molecules and vaccines comprising such modified TNF alpha molecules and DNA
05/10/2000CN1052240C Method for preparing inhibitor of retroinfection viral protease
05/09/2000CA2153584C Cytokine restraining agents
05/09/2000CA1340985C Peptide derivatives
05/03/2000EP0996455A1 $g(a)-O-LINKED GLYCOCONJUGATES WITH CLUSTERED (2,6)-ST EPITOPES, METHODS OF PREPARATION AND USES THEREOF
04/2000
04/27/2000WO2000023092A1 Contulakin-g, analogs thereof and uses therefor
04/11/2000CA1340957C Nikkomycin derivatives, antimycotic compositions of nikkomycin derivatives and azole antimycotics
04/06/2000WO2000018904A2 Secreted proteins and nucleic acids encoding them
03/2000
03/30/2000WO2000017226A1 Synthetic peptides, conjugation reagents and methods
03/21/2000US6040146 Detection of mammary tumor virus-like sequences in human breast cancer
03/14/2000US6037447 Glycopeptide compounds
03/14/2000US6037324 Madcam-1 (mucosal addressin cell adhesion molecule-1); useful in the treatment of inflammatory bowel diseases and other diseases involving leukocyte infiltration of the gastrointestinal tract or other mucosal tissues
03/07/2000US6034055 Glycosyl-amides of 2-aminoacylamino-2-deoxy-sugars
03/07/2000US6033669 Methods for generating cytotoxic T cells and treatment of diseases thereby
03/01/2000EP0981542A1 20(s) camptothecin glycoconjugates
02/2000
02/24/2000WO2000009546A1 Process for the preparation of regular glycopeptides
02/22/2000US6027648 A separating agent comprising a stationary phase in which ovomucoid part of which has been modified and a carrier on which the modified ovomucoid has been immobilized, contacting the separating agent with the mixture of optical isomers
02/16/2000CN1244802A Reductive alkylation of glycopeptide antibiotics
02/02/2000EP0975668A1 MODIFIED TNF$g(a) MOLECULES, DNA ENCODING SUCH MODIFIED TNF$g(a) MOLECULES AND VACCINES COMPRISING SUCH MODIFIED TNF$g(a) MOLECULES AND DNA
01/2000
01/27/2000WO2000004044A1 Glycopeptide antibiotics, combinatorial libraries of glycopeptide antibiotics and methods of producing same
01/27/2000CA2337103A1 Glycopeptide antibiotics, combinatorial libraries of glycopeptide antibiotics and methods of producing same
01/25/2000US6018062 17-difluoromethylene-estratrienes
01/25/2000CA2027629C Glycopeptide antibiotics
01/20/2000WO1998027107A8 Method of coupling polysaccharides to proteins
01/12/2000EP0969873A1 Multiple antigen glycopeptide carbohydrate, vaccine comprising the same and use thereof
12/1999
12/29/1999EP0556292B1 Hepatitis c virus asialoglycoproteins
12/28/1999US6008333 Preparation of glucosaminyl muramic acid derivatives
12/28/1999CA1340861C Cysteine-depleted muteins of biologically active proteins
12/23/1999WO1999065934A1 Antithrombotic compounds
12/22/1999EP0964690A1 Peptide-lipid conjugates, liposomes and liposomal drug delivery
12/16/1999WO1999064378A2 Directed combinatorial compound library and high throughput assays for screening same
12/16/1999CA2334338A1 Directed combinatorial compound library and high throughput assays for screening same
12/14/1999US6001823 Novel pyranosides which are believed to be capable of interacting with periplasmic molecular chaperones
12/09/1999WO1999063346A1 Method and device for electrochemical immunoassay of multiple analytes
12/09/1999WO1999062919A1 Redox reversible bipyridyl osmium complex conjugates
12/09/1999WO1999062918A1 Redox reversible imidazole-osmium complex conjugates
12/07/1999US5998581 Reductive alkylation of glycopeptide antibiotics
12/07/1999US5998362 Conjugates useful in the treatment of prostate cancer
11/1999
11/30/1999US5994297 Therapy for Staphylococcus aureus
11/25/1999WO1999048515A9 Trimeric antigenic o-linked glycopeptide conjugates, methods of preparation and uses thereof
11/24/1999EP0749446B1 Highly reactive esters of carboxy polysaccharides and novel carboxy polysaccharides derived therefrom
11/17/1999EP0956000A1 Synthesis of glycophospholipid and peptide-phospholipid conjugates and uses thereof
11/17/1999EP0819135B1 Sugar-modified cytostatics
11/11/1999WO1999056760A1 N1-modified glycopeptides
11/11/1999CA2330619A1 N1-modified glycopeptides
11/09/1999US5981720 Carrier glucosylated tetrapeptide comprising a tetrapeptide of glycine, asparagine, lysine and acetylglycosamine; as antidiabetic agents for non-insulin dependent diabetes and viricides to treat human immunodeficiency virus infections
11/02/1999US5977296 Chiral peptide nucleic acid monomers and oligomers
11/02/1999US5977063 Alkylated hexapeptides
11/02/1999US5977062 Active against antibiotic resistant bacteria
10/1999
10/27/1999CN1233257A Polypeptide transition metal salts and method of enhancing anti-HIV activity of polypeptide
10/05/1999US5962660 Compound which suppresses selectin-mediated cellular adhesion; for stable antiinflammatory agents with better bioavailability and greater activity which are easier to synthesize
10/05/1999US5962216 Tumor-activated prodrug compounds and treatment
09/1999
09/30/1999WO1999048515A1 Trimeric antigenic o-linked glycopeptide conjugates, methods of preparation and uses thereof
09/30/1999DE19813137A1 New camptothecin glyco-conjugate compounds
09/30/1999CA2324616A1 Trimeric antigenic o-linked glycopeptide conjugates, methods of preparation and uses thereof
09/22/1999EP0615522B1 Muramyl compounds for treatment of septic shock
09/21/1999US5955589 Gapped 2' modified oligonucleotides
09/21/1999US5955578 Synthetic matrix of synthetic polypeptide including amino acid sequence of d-arginine-glycine-aspartic acid, a biodegradable polymer, and optional crosslinking agent; temporary wound healing agent which promotes cell migration
09/14/1999US5952466 Reductive alkylation of glycopeptide antibiotics
09/14/1999US5952310 Bactericides
09/08/1999EP0939765A1 Glycoconjugates of modified camptothecin derivatives (a- or b-ring linkage)
09/07/1999US5948895 Process for producing a glycosylated amino compound
08/1999
08/26/1999WO1999042476A1 Novel antibacterial agents
08/26/1999CA2318394A1 Novel antibacterial agents
08/18/1999EP0722332B1 Treatment of precancerous lesions by muramyl peptides
08/17/1999US5939523 Purification of dalbaheptide antibiotics by isoelectric focusing
08/17/1999US5939382 Pyridine-borane as a reducing agent
08/17/1999US5939273 Incubating galactosyl epitope labeled combinatorial library members with cellular or protein targets, washing away non-specifically bound members, incubating with anti-galactosyl antibodies for detectable signal; complement cascade
08/11/1999EP0934076A1 Solid phase lipoglycopeptide library, compositions and methods
08/10/1999US5936074 Reacting teicoplanin with echinocandin beta deacylase, then forming salt and/or deprotecting amino group; bactericides against gram-positive bacteria
07/1999
07/21/1999EP0929569A1 Methods of alleviating neuropathic pain using prosaposin-derived peptides
07/13/1999US5922548 Anti α-gal screening technique
1 ... 12 13 14 15 16 17 18 19 20 21 22 23 24 25 26 27 28 29 30 31 32 ... 34